Glucagon-like peptide-1 is a physiological incretin in rat

Journal of Clinical Investigation

Volumn 95, Issue 1, 1995, Pages 417-421

  Wang, Zhili ^a   Wang, Ren Ming ^a   Owji, Ali A ^a   Smith, David M ^a   Ghatei, Mohammad A ^a   Bloom, Stephen R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

gastric inhibitory polypeptide; glucagon; glucose; insulin; cell

Indexed keywords

ARGININE; EXENDIN[9-39]; GLUCAGON; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HORMONE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HORMONE RECEPTOR INTERACTION; INSULIN RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEDIATOR; NONHUMAN; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0028821658     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci117671     Document Type: Article

References (29)

1. Unger, R. H., and A. M. Eisentraut. 1969. Entero-insular axis. Arch. Intern. Med. 123:261-266.
2. Ebert, R., and W. Creutzfeld. 1987. Gastrointestinal peptides and insulin secretion. Diab. Metab. Rev. 3:1-16.
3. Dupre, J. 1991. The endocrine pancreas. Raven Press, New York. 253 pp.
4. Dupre, J., S. A. Ross, D. Watson, and J. C. Brown. 1973. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J. Clin. Endocrinol. & Metab. 37:826-828.
5. Nauck, M., W. Schmidt, J. Ebert, J. Strietzel, P. Cantor, G. Hoffman, and W. Creutzfeldt. 1989. Insulinotropic properties of synthetic human gastric inhibitory peptide in man: interactions with glucose, phenylalanine, and cholecystokinin 8. J. Clin. Endocrinol. & Metab. 69:654-662.
6. Kreymann, B., G. Williams, M. A. Ghatei, and S. R. Bloom. 1987. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 2:1300-1304.
7. Mojsov, S., G. C. Weir, and J. F. Habener. 1987. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79:616-619.
8. Holst, J. J., C. Orskov, O. V. Nielsen, and T. W. Schwartz. 1987. Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS (Fed. Eur. Biochem. Soc.) Lett. 211:169-174.
9. Mojsov, S., M. G. Kopczynski, and J. F. Habener. 1990. Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas. J. Biol. Chem. 265:8001-8008.
10. Orskov, C., M. Bersani, A. H. Johnsen, P. Hojrup, and J. J. Holst. 1989. Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J. Biol. Chem. 264:12826-12829.
11. Varndell, I. M., A. E. Bishop, K. L. Sikri, L. O. Uttenthal, S. R. Bloom, and J. M. Polak. 1985. Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J. Histochem. Cytochem. 33:1080-1086.
12. D'Alesio, D., R. Thirlby, E. Laschansky, H. Zebroski, and J. Ensinck. 1993. Response of tGLP-1 to nutrients in humans. Digestion. 54(6):377-379.
13. Eng, J., W. A. Kleinman, L. Singh, G. Singh, and J. P. Raufman. 1992. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J. Biol. Chem. 267:7402-7405.
14. Malhotra, R., L. Singh, J. Eng, and J. P. Raufman. 1992. Exendin-4, a new peptide from Heloderma suspectum venom, potentiates cholecystokinin-induced amylase release from rat pancreatic acini. Regul. Pept. 41:149-156.
15. Thorens, B., A. Porret, L. Buhler, S. P. Deng, P. Morel, and C. Widmann. 1993. Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. Diabetes. 42:1678-1682.
16. Goke, R., H. C. Fehmann, T. Linn, H. Schmidt, M. Krause, J. Eng, and B. Goke. 1993. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J. Biol. Chem. 268:19650-19655.
17. Fracker, P. J., and J. C. Speck. 1978. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6,-tetrachloro-3α,-6α,diphenylglycoluril. Biochem. Biophys. Res. Commun. 80:849-857.
18. Suda, K., D. M. Smith, M. A. Ghatei, J. K. Murphy, and S. R. Bloom. 1991. Investigation and characterisation of receptors for PACAP (pituitary adenylate cyclase activating polypeptide) in human brain by radioligand binding and chemical cross-linking. J. Clin. Endocrinol. & Metab. 72:958-964.
19. Suda, K., D. M. Smith, M. A. Ghatei, and S. R. Bloom. 1992. Investigation of the interaction of VIP binding sites with VIP and PACAP in human brain. Neurosci. Lett. 137:19-23.
20. Bhogal, R., D. M. Smith, P. Purkiss, and S. R. Bloom. 1993. Molecular identification of binding sites for calcitonin gene-related peptide (CGRP) and islet amyloid polypeptide (IAPP) in mammalian lung: Species variation and binding of truncated CGRP and IAPP. Endocrinology. 133:2351-2361.
21. Kanse, S. M., B. Kreymann, M. A. Ghatei, and S. R. Bloom. 1988. Identification and characterisation of glucagon-like peptide-1 7-36 amide-binding sites in the rat brain and lung. FEBS (Fed. Eur. Biochem. Soc.) Lett. 241:209-212.
22. Rodbell, G., M. J. Krans, S. L. Pohl, and L. Birnbaumer. 1971. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. III Binding of glucagon: method of assay and specificity. J. Biol. Chem. 246:1861-1871.
23. Albano, J. D. M., R. P. Ekins, G. Maritz, and R. C. Turner. 1972. A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free moieties. Acta Endocrinol. 70:487-509.
24. Comparison of several groups. 1987. Armitage P, Berry G. Statistical Methoda in Medical Research. 2nd ed. Blackwell, Oxford, England. 186-213.
25. Dockray, G. J. 1989. Handbook of Physiology. American Physiology Society, Bethesda, MD. 133 pp.
26. Wettergren, A., B. Schjoldager, P. E. Mortensen, J. Myhre, J. Christiansen, and J. J. Holst. 1993. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig. Dis. Sci. 38:665-673.
27. Gutniak, M., C. Orskov, J. J. Holst, B. Ahren, and S. Efendic. 1992. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N. Engl. J. Med. 326:1316-1322.
28. Fehmann, H. C., and J. F. Habener. 1992. Insulinotropic hormone glucagon-like peptide-I (7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells. Endocrinology. 130:159-166.
29. Nauck, M. A., N. Kleine, C. Orskov, J. J. Holst, B. Willms, and W. Creutzfeldt. 1993. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 36:741-744.